{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-080475","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2026-07-22T21:26:11+00:00","discovered_at":"2026-07-22T21:28:00.279081+00:00","generated_at":"2026-07-22T21:28:09.489640+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"China Pharma prices $5M registered direct offering of 2.5M shares at $2/share","bullets":["Gross proceeds of $5M from sale of 2.5M shares at $2.00 per share.","FT Global Capital acting as exclusive placement agent; 7% cash fee.","Net proceeds to be used for working capital and general corporate purposes.","Investor gets 40% participation right in subsequent financings for 3 months; 91-day lock-up on variable rate transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-080475","json":"https://secwatch.observer/filing/0001213900-26-080475.json","markdown":"https://secwatch.observer/filing/0001213900-26-080475.md","text":"https://secwatch.observer/filing/0001213900-26-080475.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390026080475/0001213900-26-080475-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390026080475/ea0298921-8k_china.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-22T21:28:09.489640+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}